What is the current valuation of the Hematopoietic Stem Cell Transplantation Market?

As of 2024, the market valuation was 3.923 USD Billion. Read More

What is the projected market size for the Hematopoietic Stem Cell Transplantation Market by 2035?

The market is projected to reach 13.52 USD Billion by 2035. Read More

What is the expected CAGR for the Hematopoietic Stem Cell Transplantation Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 11.9%. Read More

Which companies are considered key players in the Hematopoietic Stem Cell Transplantation Market?

Key players include Novartis, Bristol-Myers Squibb, Amgen, Gilead Sciences, Celgene, Takeda, Roche, Merck, and AstraZeneca. Read More

What are the main segments of the Hematopoietic Stem Cell Transplantation Market?

The main segments include Transplant Type, Indication, and Application. Read More

What was the market value for Allogeneic and Autologous transplants in 2024?

In 2024, both Allogeneic and Autologous transplants were valued at 1.9615 USD Billion. Read More

How does the market value for Acute Myeloid Leukemia compare to other indications?

Acute Myeloid Leukemia had a market value of 1.2 USD Billion in 2024, making it one of the leading indications. Read More

What is the projected market value for Peripheral Blood Stem Cells Transplant by 2035?

The market value for Peripheral Blood Stem Cells Transplant is projected to reach 6.5 USD Billion by 2035. Read More

What was the market valuation for Cord Blood Transplant in 2024?

The market valuation for Cord Blood Transplant was 0.623 USD Billion in 2024. Read More

Which indication is expected to show the highest growth in the Hematopoietic Stem Cell Transplantation Market?

Non-Hodgkin Lymphoma, with a projected value of 3.1 USD Billion by 2035, appears to show substantial growth potential. Read More

Hematopoietic Stem Cell Transplantation Market

Hematopoietic Stem Cell Transplantation Market Research Report Information by Transplant Type (Allogeneic and Autologous), by Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Other Non-Malignant Disorders), by Application (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Cord Blood Transplant), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2035

Forecast Period

2025 - 2035

CAGR

11.9%

2024 Market Size

$ 3.92 Billion

2035 Market Size

$ 13.52 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/19949-CR | Pages: 128 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Transplant Type (USD Billion)
  1. 4.1.1 Allogeneic
  2. 4.1.2 Autologous
2. 4.2 Healthcare, BY Indication (USD Billion)
  1. 4.2.1 Acute Myeloid Leukemia
  2. 4.2.2 Acute Lymphoblastic Leukemia
  3. 4.2.3 Hodgkin Lymphoma
  4. 4.2.4 Non-Hodgkin Lymphoma
  5. 4.2.5 Multiple Myeloma
  6. 4.2.6 Other Non-Malignant Disorders
3. 4.3 Healthcare, BY Application (USD Billion)
  1. 4.3.1 Bone Marrow Transplant
  2. 4.3.2 Peripheral Blood Stem Cells Transplant
  3. 4.3.3 Cord Blood Transplant
4. 4.4 Healthcare, BY Region (USD Billion)
  1. 4.4.1 North America
    1. 4.4.1.1 US
    2. 4.4.1.2 Canada
  2. 4.4.2 Europe
    1. 4.4.2.1 Germany
    2. 4.4.2.2 UK
    3. 4.4.2.3 France
    4. 4.4.2.4 Russia
    5. 4.4.2.5 Italy
    6. 4.4.2.6 Spain
    7. 4.4.2.7 Rest of Europe
  3. 4.4.3 APAC
    1. 4.4.3.1 China
    2. 4.4.3.2 India
    3. 4.4.3.3 Japan
    4. 4.4.3.4 South Korea
    5. 4.4.3.5 Malaysia
    6. 4.4.3.6 Thailand
    7. 4.4.3.7 Indonesia
    8. 4.4.3.8 Rest of APAC
  4. 4.4.4 South America
    1. 4.4.4.1 Brazil
    2. 4.4.4.2 Mexico
    3. 4.4.4.3 Argentina
    4. 4.4.4.4 Rest of South America
  5. 4.4.5 MEA
    1. 4.4.5.1 GCC Countries
    2. 4.4.5.2 South Africa
    3. 4.4.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novartis (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bristol-Myers Squibb (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Amgen (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Gilead Sciences (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Celgene (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Takeda (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Roche (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AstraZeneca (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TRANSPLANT TYPE
4. 6.4 US MARKET ANALYSIS BY INDICATION
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 CANADA MARKET ANALYSIS BY TRANSPLANT TYPE
7. 6.7 CANADA MARKET ANALYSIS BY INDICATION
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 EUROPE MARKET ANALYSIS
10. 6.10 GERMANY MARKET ANALYSIS BY TRANSPLANT TYPE
11. 6.11 GERMANY MARKET ANALYSIS BY INDICATION
12. 6.12 GERMANY MARKET ANALYSIS BY APPLICATION
13. 6.13 UK MARKET ANALYSIS BY TRANSPLANT TYPE
14. 6.14 UK MARKET ANALYSIS BY INDICATION
15. 6.15 UK MARKET ANALYSIS BY APPLICATION
16. 6.16 FRANCE MARKET ANALYSIS BY TRANSPLANT TYPE
17. 6.17 FRANCE MARKET ANALYSIS BY INDICATION
18. 6.18 FRANCE MARKET ANALYSIS BY APPLICATION
19. 6.19 RUSSIA MARKET ANALYSIS BY TRANSPLANT TYPE
20. 6.20 RUSSIA MARKET ANALYSIS BY INDICATION
21. 6.21 RUSSIA MARKET ANALYSIS BY APPLICATION
22. 6.22 ITALY MARKET ANALYSIS BY TRANSPLANT TYPE
23. 6.23 ITALY MARKET ANALYSIS BY INDICATION
24. 6.24 ITALY MARKET ANALYSIS BY APPLICATION
25. 6.25 SPAIN MARKET ANALYSIS BY TRANSPLANT TYPE
26. 6.26 SPAIN MARKET ANALYSIS BY INDICATION
27. 6.27 SPAIN MARKET ANALYSIS BY APPLICATION
28. 6.28 REST OF EUROPE MARKET ANALYSIS BY TRANSPLANT TYPE
29. 6.29 REST OF EUROPE MARKET ANALYSIS BY INDICATION
30. 6.30 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
31. 6.31 APAC MARKET ANALYSIS
32. 6.32 CHINA MARKET ANALYSIS BY TRANSPLANT TYPE
33. 6.33 CHINA MARKET ANALYSIS BY INDICATION
34. 6.34 CHINA MARKET ANALYSIS BY APPLICATION
35. 6.35 INDIA MARKET ANALYSIS BY TRANSPLANT TYPE
36. 6.36 INDIA MARKET ANALYSIS BY INDICATION
37. 6.37 INDIA MARKET ANALYSIS BY APPLICATION
38. 6.38 JAPAN MARKET ANALYSIS BY TRANSPLANT TYPE
39. 6.39 JAPAN MARKET ANALYSIS BY INDICATION
40. 6.40 JAPAN MARKET ANALYSIS BY APPLICATION
41. 6.41 SOUTH KOREA MARKET ANALYSIS BY TRANSPLANT TYPE
42. 6.42 SOUTH KOREA MARKET ANALYSIS BY INDICATION
43. 6.43 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
44. 6.44 MALAYSIA MARKET ANALYSIS BY TRANSPLANT TYPE
45. 6.45 MALAYSIA MARKET ANALYSIS BY INDICATION
46. 6.46 MALAYSIA MARKET ANALYSIS BY APPLICATION
47. 6.47 THAILAND MARKET ANALYSIS BY TRANSPLANT TYPE
48. 6.48 THAILAND MARKET ANALYSIS BY INDICATION
49. 6.49 THAILAND MARKET ANALYSIS BY APPLICATION
50. 6.50 INDONESIA MARKET ANALYSIS BY TRANSPLANT TYPE
51. 6.51 INDONESIA MARKET ANALYSIS BY INDICATION
52. 6.52 INDONESIA MARKET ANALYSIS BY APPLICATION
53. 6.53 REST OF APAC MARKET ANALYSIS BY TRANSPLANT TYPE
54. 6.54 REST OF APAC MARKET ANALYSIS BY INDICATION
55. 6.55 REST OF APAC MARKET ANALYSIS BY APPLICATION
56. 6.56 SOUTH AMERICA MARKET ANALYSIS
57. 6.57 BRAZIL MARKET ANALYSIS BY TRANSPLANT TYPE
58. 6.58 BRAZIL MARKET ANALYSIS BY INDICATION
59. 6.59 BRAZIL MARKET ANALYSIS BY APPLICATION
60. 6.60 MEXICO MARKET ANALYSIS BY TRANSPLANT TYPE
61. 6.61 MEXICO MARKET ANALYSIS BY INDICATION
62. 6.62 MEXICO MARKET ANALYSIS BY APPLICATION
63. 6.63 ARGENTINA MARKET ANALYSIS BY TRANSPLANT TYPE
64. 6.64 ARGENTINA MARKET ANALYSIS BY INDICATION
65. 6.65 ARGENTINA MARKET ANALYSIS BY APPLICATION
66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TRANSPLANT TYPE
67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY INDICATION
68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
69. 6.69 MEA MARKET ANALYSIS
70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY TRANSPLANT TYPE
71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY INDICATION
72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY TRANSPLANT TYPE
74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY INDICATION
75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
76. 6.76 REST OF MEA MARKET ANALYSIS BY TRANSPLANT TYPE
77. 6.77 REST OF MEA MARKET ANALYSIS BY INDICATION
78. 6.78 REST OF MEA MARKET ANALYSIS BY APPLICATION
79. 6.79 KEY BUYING CRITERIA OF HEALTHCARE
80. 6.80 RESEARCH PROCESS OF MRFR
81. 6.81 DRO ANALYSIS OF HEALTHCARE
82. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
83. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
84. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
85. 6.85 HEALTHCARE, BY TRANSPLANT TYPE, 2024 (% SHARE)
86. 6.86 HEALTHCARE, BY TRANSPLANT TYPE, 2024 TO 2035 (USD Billion)
87. 6.87 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
88. 6.88 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Billion)
89. 6.89 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
90. 6.90 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TRANSPLANT TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY INDICATION, 2025-2035 (USD Billion)
  3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Hematopoietic Stem Cell Transplantation Market Segmentation

Hematopoietic Stem Cell Transplantation Market By Transplant Type (USD Billion, 2025-2035)

Allogeneic
Autologous

Hematopoietic Stem Cell Transplantation Market By Indication (USD Billion, 2025-2035)

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Other Non-Malignant Disorders

Hematopoietic Stem Cell Transplantation Market By Application (USD Billion, 2025-2035)

Bone Marrow Transplant
Peripheral Blood Stem Cells Transplant
Cord Blood Transplant

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”